Probiotics Improve Constipation
ConditionConstipation
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorWecare Probiotics Co., Ltd.
About this trial
This study is a randomized, double-blind, placebo-controlled trial in which adult subjects with constipation are randomly assigned to either a probiotic group or a placebo group for an 8-week intervention. Through blood and fecal sample analyses combined with multidimensional questionnaire assessments, the study aims to systematically evaluate the efficacy of probiotics in improving gastrointestinal function, immune status, and mental health in patients with constipation.
Eligibility criteria
Qualifiers
Aged 18 to 65 years (inclusive).
Diagnosed with constipation, defined as fewer than 3 spontaneous bowel movements per week and/or Bristol Stool Form Scale types 1 or 2.
Willing and able to comply with the study protocol and complete all required assessments.
Provide written informed consent prior to any study-related procedures.
Disqualifiers
Use of products with functions similar to the investigational product within a short period prior to screening that may interfere with the evaluation of study outcomes.
Intention to change dietary habits significantly during the study period.
Severe allergies or immunodeficiency.
Women who are pregnant, breastfeeding, or planning to become pregnant during the trial.
Trial design
Treatments tested in this trial
- Probitics
- Placebo
Treatment groups
76 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov